Well this is certainly post-#EHA2025 news to return to! Happy days.

LAST CHANCE to register for our #MPN Post-#EHA2025 highlights webinar taking place TOMORROW🚨 💻 The #MPNs session will be chaired by Claire Harrison & moderated by Dr John Mascarenhas & J.J. Kiladjian AGENDA 👉 vjhemonc.com/event/post-eha… REGISTER 👉 us06web.zoom.us/webinar/regist…

A Day in the Life of a Governance Specialist by Dan Walker Joint Research Office……. A fantastic blog by Dan from the R&D team insights into the critical work done to facilitate research in the Trust! Unsung heroes making ground breaking research happen jointresearchoffice.org/news-and-event…

Delighted to be at the Blood Cancer UK Research Symposium A fantastic range of speakers Rubina Ahmed director of research kicking off today with a reminder of why this work is so important set in seven “becauses” Blood Cancer UK @MPNSM

I've #justsponsored claire woodley, who's fundraising for MPN Voice (Guy's and St Thomas' Charity) on JustGiving. Donate now justgiving.com/page/claire-wo…

Hear from John Mascarenhas, on INCA33989, a novel, first in class, mutant #calreticulin-specific #monoclonalantibody that demonstrates safety and efficacy in patients with essential #thrombocythemia (ET), in our Post-EHA 2025 #MPNs Highlights 🤔 🩸🎥 Chair: Claire Harrison

Blood cancer takes so much from people’s lives, and it also takes incredible strength to face it. We’re launching a campaign this #BloodCancerAwarenessMonth to show the reality of it 🩸

Yesterday, our campaign lit up in Birmingham New Street station! 🚂 Every 14 minutes, someone in the UK is diagnosed with blood cancer. Raising awareness means more people will know about us, find support, and help fund the research we need to beat it.

Today is MPN Awareness day, shining a light on blood cancers like essential thrombocythaemia (ET), polycythaemia vera (PV) and myelofibrosis (MF). We know what it takes to live with an MPN - if you or someone you know lives with one, share this post to support.

So vital for us to get this information so please fill in if you can and do repost/circulate to all MPN patients who have been on interferon. Thank you 😊 GUY'S MYELOID CENTRE #MPN

A joy to walk with some of GSTT team MPN this morning to raise awareness of MPN and Blood Cancer! The weather was kind and after a total of 30 miles between us the coffee and croissant were welcome!! Great job team MPN Voice @MPNSM GUY'S MYELOID CENTRE Blood Cancer UK

When treatment ends, the challenges don’t necessarily finish too. Blood cancer never really leaves you; it can keep taking. Your energy. Your time. Your comfort. If you feel everyone else has moved on, our community is still here. We know what it takes, and we’ll support you.

Chronic lymphocytic leukemia (CLL) cells reprogram their tumor microenvironment (TME) to promote drug resistance and tumor progression. Authors 3D approach reveals that CLL B cells upregulate the AP-1 transcription factor, conferring protection against therapy-induced cell death.

✨ 𝗧𝗵𝗲 𝟴𝘁𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗜𝗔𝗖𝗛 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗸𝗶𝗰𝗸𝘀 𝗼𝗳𝗳 𝗻𝗲𝘅𝘁 𝘄𝗲𝗲𝗸! Looking forward to welcoming everyone – see you at the Opening Session on 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆, 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟵𝘁𝗵! 🔗 View the full program: iach.cme-congresses.com/program/ 📝 You can still

Dial in and join us in this fantastic meeting to hear the latest updates discussed and debated

👉👉👉Kicking off 8th annual IACH Paris 🇫🇷 meeting with our 4th annual MPNCo&D Congress track ! Mohamad Mohty Bipin Savani Arnon Nagler | MPNCo&D Congress Co-chairs Naveen Pemmaraju, MD Claire Harrison Ruben A. Mesa, MD || #MPNSM

1) Welcome to a 🆕 CE/#CME-accredited tweetorial, brought to you by the expert faculty of @onc_ce! Our program concerns the foundational understanding of #myelofibrosis #MF & in particular the symptom and financial burdens of #anaemia that accompany the disease.

2) We welcome new expert faculty member, Dr Claire Harrison Claire Harrison, clinician, educator, & Prof of Haematology at the Guy’s & St. Thomas’ NHS Foundation Trust Guy's and St Thomas' in London 🇬🇧, where she is also Prof of Myeloproliferative Neoplasms & Deputy Chief Medical Officer

3a) This tweetorial is accredited for 🆓0.75hr CE/#CME, is intended for #HCPs, & is supported by an educational grant from Bristol Myers Squibb. Statement of accreditation & faculty disclosures are at oncologytweetorials-ce.com/disclosures/. Follow this 🧵 for credit. Follow US for more #MedEd!

So important to get this information in order to improve awareness and access to trials - do retweet and spread the word among patients